Prostate Cancer Progression and Survival in BRCA2 Mutation Carriers (Q58143504)

7

object named as

T. Rafnar

0 references

Erik G Jönsson

9

object named as

E. Jonsson

0 references

author name string

L. Vidarsdottir

2

0 references

T. Thorgeirsson

3

0 references

J. G. Jonasson

4

0 references

E. J. Olafsdottir

5

0 references

G. H. Olafsdottir

6

0 references

S. Thorlacius

8

0 references

J. E. Eyfjord

10

0 references

H. Tulinius

Journal of the National Cancer Institute

11

0 references

language of work or name

English

0 references

publication date

12 June 2007

0 references

published in

0 references

volume

99

0 references

issue

12

0 references

page(s)

929-935

0 references

cites work

Prostate cancer--look to Denmark?

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005

Analysis of recent trends in prostate cancer incidence and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005

Adenocarcinoma of the prostate in Iceland: A population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005

BRCA2 mutation in Icelandic prostate cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005

Cancer risks in BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005

The effect of a single BRCA2 mutation on cancer in Iceland

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005

Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005

A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005

BRCA mutations and risk of prostate cancer in Ashkenazi Jews.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005

Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005

Identification of the breast cancer susceptibility gene BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005

The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005

A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005

The Icelandic founder mutation BRCA2 999del5: analysis of expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005

Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005

The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005

The effect of year of birth on the breast cancer age-incidence curve in Iceland

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005

Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005

The Icelandic Cancer Project--a population-wide approach to studying cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005

CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 status

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005

Histologic grading of prostate cancer: a perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005

Cancer susceptibility and the functions of BRCA1 and BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005

Involvement of Brca2 in DNA repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005

Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005

Variation in cancer risks, by mutation position, in BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005

Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005

Immunohistochemical expression of BRCA2 protein and allelic loss at the BRCA2 locus in prostate cancer. CRC/BPG UK Familial Prostate Cancer Study Collaborators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM005